MedPath

Effect of Berberine on Hormonal and Metabolic Features in Obese Women With Polycystic Ovary Syndrome (PCOS)

Not Applicable
Conditions
Polycystic Ovary Syndrome
Obesity
Interventions
Drug: Placebo
Registration Number
NCT01138930
Lead Sponsor
Heilongjiang University of Chinese Medicine
Brief Summary

Berberine has showed effective in lowering blood sugar levels in db/db mice and anti-dyslipidemia in human.Studies on the effect of berberine on metabolic and hormonal features of women with polycystic ovary syndrome (PCOS) are lacking.The objective of this study is to examine the effect of Berberine metabolic and hormonal parameters and insulin resistance in obese patients with PCOS.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlacebo-
BerberineBerberine-
Primary Outcome Measures
NameTimeMethod
Whole body insulin action3 months

Glucose Disposal Rate measured by hyperinsulinemic euglycemic clamp

Secondary Outcome Measures
NameTimeMethod
Oral glucose tolerance test (OGTT)3 months
Ovarian androgen biosynthesis3 months
Hormonal profile3 months
Fasting lipid metabolic profile3 months
Renal and liver function tests3 months
Adverse events3 months
6) Weight, waist/hip circumference, blood pressure, F-G score and acne before and after treatment.Three months

Trial Locations

Locations (4)

First Affliated Hospital of Harbin Medical University

🇨🇳

Harbin, Heilongjiang, China

Affiliated Hospital of Guangzhou Medical University

🇨🇳

Guangzhou, Guangdong, China

Forth Affiliated Hospital of Harbin Medcal University

🇨🇳

Harbin, Heilongjiang, China

Department of Obstetrics and Gynecology,First Affliated Hospital,Heilongjiang University of Chinese Medicine .

🇨🇳

Harbin, Heilongjiang, China

© Copyright 2025. All Rights Reserved by MedPath